Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors. (2021)

First Author: Bofinger R

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d1nr02770k

PubMed Identifier: 34730152

Publication URI: http://europepmc.org/abstract/MED/34730152

Type: Journal Article/Review

Volume: 13

Parent Publication: Nanoscale

Issue: 44

ISSN: 2040-3364